Optimal activated clotting time during peripheral artery endovascular procedures: cutting the gordian knot.
Journal
The Journal of cardiovascular surgery
ISSN: 1827-191X
Titre abrégé: J Cardiovasc Surg (Torino)
Pays: Italy
ID NLM: 0066127
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
medline:
2
6
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
ppublish
Résumé
All endovascular procedures need an effective anticoagulation regimen that avoids thrombo-embolic complications due to the insertion and manipulation of various intravascular devices. Systemic heparinization reduces the risk of thrombosis but there is no conclusive evidence regarding the correct use of anticoagulant medications and accordant monitoring, especially in endovascular peripheral arterial procedures. Anticoagulation must be maintained during the whole vascular procedure, especially during partial or complete blood flow interruption. Reaching and maintaining the correct coagulative status is mandatory to avoid or reduce thromboembolic complications that could limit the procedure's effectiveness or be harmful to the patient. Patients' baseline variables and procedure-related elements can influence the way anticoagulation should be administered and how coagulative status has to be monitored. This review aimed to clarify the critical points of anticoagulation and monitoring management for non-cardiac arterial procedures in order to understand the best way to manage vascular procedures anticoagulation.
Identifiants
pubmed: 37260152
pii: S0021-9509.23.12703-0
doi: 10.23736/S0021-9509.23.12703-0
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM